Skip to main content
. 2026 Jun 20;27(12):5587. doi: 10.3390/ijms27125587
BP Bullous Pemphigoid
DABP Drug-Associated Bullous Pemphigoid
DIF Direct Immunofluorescence
IIF Indirect Immunofluorescence
ELISA Enzyme-linked immunosorbent assay
NC16A Non-collagenous 16A domain
NC7-Col4 NC-7-collagenous IV region
DPP-4 Dipeptidyl peptidase-4
ICI Immune Checkpoint Inhibitor
IgE Immunoglobulin E
IgG Immunoglobulin G
IL-4 Interleukin-4
IL-13 Interleukin-13
BPDAI Bullous Pemphigoid Disease Area Index
NRS Numeric Rating Scale
CI Confidence Interval
OR Odds Ratio
IQR Interquartile Range
SD Standard Deviation
FDR False discovery rate
HLA Human Leukocyte Antigen